Subscribe To
OSUR / OraSure Technologies (OSUR) Reports Q2 Loss, Tops Revenue Estimates
OSUR News
By Zacks Investment Research
August 3, 2023
OraSure Technologies (OSUR) Reports Q2 Loss, Tops Revenue Estimates
OraSure Technologies (OSUR) came out with a quarterly loss of $0.07 per share versus the Zacks Consensus Estimate of a loss of $0.06. This compares to more_horizontal
By Seeking Alpha
May 15, 2023
OraSure Technologies: As Good As It Gets
Today, we take our first look at OraSure Technologies, Inc., which has seen a huge and recent surge of revenues. However, this was almost entirely due more_horizontal
By Seeking Alpha
May 10, 2023
OraSure Technologies, Inc. (OSUR) Q1 2023 Earnings Call Transcript
OraSure Technologies, Inc. (NASDAQ:OSUR ) Q1 2023 Earnings Conference Call May 10, 2023 5:00 PM ET Company Participants Scott Gleason - Head of Invest more_horizontal
By Zacks Investment Research
May 10, 2023
OraSure Technologies (OSUR) Q1 Earnings and Revenues Beat Estimates
OraSure Technologies (OSUR) came out with quarterly earnings of $0.37 per share, beating the Zacks Consensus Estimate of $0.16 per share. This compare more_horizontal
By GlobeNewsWire
May 3, 2023
2023 First Quarter Earnings Conference Call Wednesday, May 10, 2023, 5:00 p.m. ET
BETHLEHEM, Pa., May 03, 2023 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering more_horizontal
By Zacks Investment Research
April 21, 2023
Is OraSure Technologies (OSUR) Outperforming Other Medical Stocks This Year?
Here is how OraSure Technologies (OSUR) and Acadia Pharmaceuticals (ACAD) have performed compared to their sector so far this year. more_horizontal
By Zacks Investment Research
April 5, 2023
OraSure (OSUR) Stock Jumps 9.3%: Will It Continue to Soar?
OraSure (OSUR) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the s more_horizontal
By Seeking Alpha
February 28, 2023
OraSure: Revising To Buy Following Extensive Growth Route
OraSure has robust growth throughout the P&L, cash flows and balance sheet. Core business exhibiting remarkable upsides without Covid-19 revenues. more_horizontal